Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia
May 1, 2016, 00:00
10.1016/j.jval.2016.03.204
https://www.valueinhealthjournal.com/article/S1098-3015(16)00272-2/fulltext
Title :
Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00272-2&doi=10.1016/j.jval.2016.03.204
First page :
A63
Section Title :
Neurological Disorders - Cost Studies
Open access? :
No
Section Order :
1539